Skip to main content
Top
Published in: Insights into Imaging 1/2019

Open Access 01-12-2019 | Pulmonary Hypertension | Pictorial Review

Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: a pictorial essay for the interventional radiologist

Authors: Yolanda C. Bryce, Rocio Perez-Johnston, Errol B. Bryce, Behrang Homayoon, Ernesto G. Santos-Martin

Published in: Insights into Imaging | Issue 1/2019

Login to get access

Abstract

Pulmonary embolus (PE) is the third most common cause of cardiovascular death with more than 600,000 cases occurring in the USA per year. About 45% of patients with acute PE will have acute right ventricular failure, and up to 3.8% of patients will develop chronic thromboembolic pulmonary hypertension (CTEPH) with progressive, severe, chronic heart failure. The right ventricle (RV) is constructed to accommodate a low-resistance afterload. Increases in afterload from acute massive and submassive PE and CTEPH may markedly compromise the RV function leading to hemodynamic collapse and death. The purpose of this educational manuscript is to instruct on the pathophysiology of RV failure in massive and submassive PE and CTEPH. It is important to understand the pathophysiology of these diseases as it provides the rationale for therapeutic intervention by the Interventional Radiologist. We review here the pathophysiology of right ventricular (RV) failure in acute massive and submassive PE and CTEPH.
Literature
1.
go back to reference Moorjani N, Price S (2013) Massive pulmonary embolus. Cardiol Clin 31:503–518.CrossRef Moorjani N, Price S (2013) Massive pulmonary embolus. Cardiol Clin 31:503–518.CrossRef
2.
go back to reference Bĕlohlávek J, Dytrych V, Linhart A (2013) Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 18(2):129–138.PubMedPubMedCentral Bĕlohlávek J, Dytrych V, Linhart A (2013) Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 18(2):129–138.PubMedPubMedCentral
3.
go back to reference Pengo V, Lensing AW, Prins MH et al (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257–2264.CrossRef Pengo V, Lensing AW, Prins MH et al (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257–2264.CrossRef
4.
go back to reference Becattini C, Agnelli G, Pesavento R et al (2006) Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 130:172–175.CrossRef Becattini C, Agnelli G, Pesavento R et al (2006) Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 130:172–175.CrossRef
5.
go back to reference Bristow MR, Zisman LS, Lowes BD et al (1998) The pressure-overloaded right ventricle in pulmonary hypertension. Chest 14:101S–106S.CrossRef Bristow MR, Zisman LS, Lowes BD et al (1998) The pressure-overloaded right ventricle in pulmonary hypertension. Chest 14:101S–106S.CrossRef
6.
go back to reference Chin KM, Kim N, Rubin LJ (2005) The right ventricle in pulmonary hypertension. Coron Artery Dis 16:13–18.CrossRef Chin KM, Kim N, Rubin LJ (2005) The right ventricle in pulmonary hypertension. Coron Artery Dis 16:13–18.CrossRef
7.
go back to reference Wiedemann HP, Matthay RA (1997) Cor Pulmonale. In: Braunwald E (ed) Heart Disease (5th ed.). W.B. Saunders Company, Philadelphia, p 1606. Wiedemann HP, Matthay RA (1997) Cor Pulmonale. In: Braunwald E (ed) Heart Disease (5th ed.). W.B. Saunders Company, Philadelphia, p 1606.
8.
go back to reference Greyson CR (2008) Pathophysiology of right ventricular failure. Crit Care Med 36:S57–S65.CrossRef Greyson CR (2008) Pathophysiology of right ventricular failure. Crit Care Med 36:S57–S65.CrossRef
9.
go back to reference Matthews JC, McLaughlin V (2008) Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev 4(1):49–59.CrossRef Matthews JC, McLaughlin V (2008) Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev 4(1):49–59.CrossRef
10.
go back to reference Wood KE (2002) Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905.CrossRef Wood KE (2002) Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905.CrossRef
11.
go back to reference McIntyre KM, Sasahara AA (1971) The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 28:288–294.CrossRef McIntyre KM, Sasahara AA (1971) The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 28:288–294.CrossRef
12.
go back to reference van Wolfere SA, Marcus JT, Westerhof N et al (2008) Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 29:120–127. van Wolfere SA, Marcus JT, Westerhof N et al (2008) Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 29:120–127.
13.
go back to reference Vlahakes GJ, Turley K, Hoffman JI (1981) The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 63:87–95.CrossRef Vlahakes GJ, Turley K, Hoffman JI (1981) The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 63:87–95.CrossRef
14.
go back to reference Page RL 2nd, O’Bryant C, Cheng D et al (2016) Drugs that may cause or exacerbate heart failure: A scientific statement from the American Heart Association. Circulation 134:e32–e69. Page RL 2nd, O’Bryant C, Cheng D et al (2016) Drugs that may cause or exacerbate heart failure: A scientific statement from the American Heart Association. Circulation 134:e32–e69.
15.
go back to reference Jaff M, McMurtry S, Archer S et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123:1788–1830. Jaff M, McMurtry S, Archer S et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123:1788–1830.
16.
go back to reference Simantirakis EN, Nakou ES, Chrysostomakis SI, Arkolaki EG, Vardas PE (2014) Simultaneous appearance of complete heart block and pulmonary embolism. The riddle of the chicken and the egg. Int J Cardiol 173:610–611. Simantirakis EN, Nakou ES, Chrysostomakis SI, Arkolaki EG, Vardas PE (2014) Simultaneous appearance of complete heart block and pulmonary embolism. The riddle of the chicken and the egg. Int J Cardiol 173:610–611.
17.
go back to reference Zarghouni M, Charles HW, Maldonado TS, Deipolyi AR (2016) Catheter-directed interventions for pulmonary embolism. Cardiovasc Diagn Ther 6(6):651–661.CrossRef Zarghouni M, Charles HW, Maldonado TS, Deipolyi AR (2016) Catheter-directed interventions for pulmonary embolism. Cardiovasc Diagn Ther 6(6):651–661.CrossRef
18.
go back to reference Han D, Kyun SL, Franquet T et al (2003) Thrombotic and nonthrombotic pulmonary arterial embolism: spectrum of imaging findings. Radiographics 23(6):1521–1539. Han D, Kyun SL, Franquet T et al (2003) Thrombotic and nonthrombotic pulmonary arterial embolism: spectrum of imaging findings. Radiographics 23(6):1521–1539.
19.
go back to reference Furlan A, Aghayev A, Chang CC et al (2012) Short-term mortality in acute pulmonary embolism: clot burden and signs of right heart dysfunction at CT pulmonary angiography. Radiology 265(1):283–293.CrossRef Furlan A, Aghayev A, Chang CC et al (2012) Short-term mortality in acute pulmonary embolism: clot burden and signs of right heart dysfunction at CT pulmonary angiography. Radiology 265(1):283–293.CrossRef
20.
go back to reference Van der Meer R, Pattynama P, van Strijen M, van der Berg-Huijsmans A, Hartmann I, Putter H (2005) Right ventricular dysfunction and pulmonary obstruction at helical CT: predication of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism 1. Radiology 235:798–803.CrossRef Van der Meer R, Pattynama P, van Strijen M, van der Berg-Huijsmans A, Hartmann I, Putter H (2005) Right ventricular dysfunction and pulmonary obstruction at helical CT: predication of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism 1. Radiology 235:798–803.CrossRef
21.
go back to reference Lu M, Demehri S, Cai T et al (2012) Axial and reformatted four-chamber right ventricle-to-left ventricle diameter ratios on pulmonary CT angiography as predictors of death after acute pulmonary embolism. AJR Am J Roentgenol 198:1353–1360. Lu M, Demehri S, Cai T et al (2012) Axial and reformatted four-chamber right ventricle-to-left ventricle diameter ratios on pulmonary CT angiography as predictors of death after acute pulmonary embolism. AJR Am J Roentgenol 198:1353–1360.
22.
go back to reference Bonderman D, Wilkens H, Wakounig S et al (2009) Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 33:325–331.CrossRef Bonderman D, Wilkens H, Wakounig S et al (2009) Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 33:325–331.CrossRef
23.
go back to reference Quarck R, Nawrot T, Meyns B, Delcroix M (2009) C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 53:1211–1218. Quarck R, Nawrot T, Meyns B, Delcroix M (2009) C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 53:1211–1218.
24.
go back to reference Quarck R, Wynants M, Verbeken E, Meyns B, Delcroix M (2015) Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Eur Respir J 46:431–443. Quarck R, Wynants M, Verbeken E, Meyns B, Delcroix M (2015) Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Eur Respir J 46:431–443.
25.
go back to reference Langer F, Schramm R, Bauer M, Tscholl D, Kunihara T, Schäfers HJ (2004) Cytokine response to pulmonary thromboendarterectomy. Chest 126:135–141. Langer F, Schramm R, Bauer M, Tscholl D, Kunihara T, Schäfers HJ (2004) Cytokine response to pulmonary thromboendarterectomy. Chest 126:135–141.
26.
go back to reference Bonderman D, Jakowitsch J, Redwan B et al (2008) Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 28:678–684.CrossRef Bonderman D, Jakowitsch J, Redwan B et al (2008) Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 28:678–684.CrossRef
27.
go back to reference Simonneau G, Torbicki A, Dorfmüller P, Kim N (2017) The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 26(143):160112. Simonneau G, Torbicki A, Dorfmüller P, Kim N (2017) The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 26(143):160112.
28.
go back to reference Delcroix M, Vonk Noordegraaf A, Fadel E, Lang I, Simonneau G, Naeije R (2013) Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J 41:224–232. Delcroix M, Vonk Noordegraaf A, Fadel E, Lang I, Simonneau G, Naeije R (2013) Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J 41:224–232.
29.
go back to reference van de Veerdonk MC, Bogaard HJ, Voelkel NF (2016) The right ventricle and pulmonary hypertension. Heart Fail Rev 21:259–271.CrossRef van de Veerdonk MC, Bogaard HJ, Voelkel NF (2016) The right ventricle and pulmonary hypertension. Heart Fail Rev 21:259–271.CrossRef
30.
go back to reference McCabe C, White PA, Hoole SP et al (2014) Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter. J Appl Physiol (1985) 116:355–363. McCabe C, White PA, Hoole SP et al (2014) Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter. J Appl Physiol (1985) 116:355–363.
31.
go back to reference Ishibashi Y, Shimada T, Nosaka S et al (1996) Effects of heart rate on coronary circulation and external mechanical efficiency in elderly hypertensive patients with left ventricular hypertrophy. Clin Cardiol 19:620–630. Ishibashi Y, Shimada T, Nosaka S et al (1996) Effects of heart rate on coronary circulation and external mechanical efficiency in elderly hypertensive patients with left ventricular hypertrophy. Clin Cardiol 19:620–630.
32.
go back to reference Murch SD, La Gerche A, Roberts TJ, Prior DL, MacIsaac AI, Burns AT (2015) Abnormal right ventricular relaxation in pulmonary hypertension. Pulm Circ 5:370–375. Murch SD, La Gerche A, Roberts TJ, Prior DL, MacIsaac AI, Burns AT (2015) Abnormal right ventricular relaxation in pulmonary hypertension. Pulm Circ 5:370–375.
33.
go back to reference Trip P, Rain S, Handoko ML et al (2015) Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension. Eur Respir J 45:1603–1612.CrossRef Trip P, Rain S, Handoko ML et al (2015) Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension. Eur Respir J 45:1603–1612.CrossRef
34.
go back to reference Lang IM, Madani M (2014) Update on chronic thromboembolic pulmonary hypertension. Circulation 130:508–518.CrossRef Lang IM, Madani M (2014) Update on chronic thromboembolic pulmonary hypertension. Circulation 130:508–518.CrossRef
35.
go back to reference Kaddoura S (2016) Echo made easy. Elsevier, London. Kaddoura S (2016) Echo made easy. Elsevier, London.
36.
go back to reference Galiè N, Humbert M, Vachiery JL et al (2015) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J 46:903–975.CrossRef Galiè N, Humbert M, Vachiery JL et al (2015) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J 46:903–975.CrossRef
37.
go back to reference Rubin LJ, American College of Chest Physicians (2004) Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 suppl):4S–6S.CrossRef Rubin LJ, American College of Chest Physicians (2004) Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 suppl):4S–6S.CrossRef
38.
go back to reference Jamieson SW, Kapelanski DP, Sakakibara N et al (2003) Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 76:1457–1462. Jamieson SW, Kapelanski DP, Sakakibara N et al (2003) Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 76:1457–1462.
39.
go back to reference Takagi H, Ota H, Sugimura K et al (2016) Dual-energy CT to estimate clinical severity of chronic thromboembolic pulmonary hypertension: comparison with invasive right heart catherization. Eur J Radiol 85(9):1574–1580.CrossRef Takagi H, Ota H, Sugimura K et al (2016) Dual-energy CT to estimate clinical severity of chronic thromboembolic pulmonary hypertension: comparison with invasive right heart catherization. Eur J Radiol 85(9):1574–1580.CrossRef
40.
go back to reference Ghofrani HA, D’Armini AM, Grimminger F et al (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369:319–329. Ghofrani HA, D’Armini AM, Grimminger F et al (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369:319–329.
41.
go back to reference Kataoka M, Inami T, Hayashida K et al (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:756–762.CrossRef Kataoka M, Inami T, Hayashida K et al (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:756–762.CrossRef
42.
go back to reference Lang I, Meyer BC, Ogo T et al (2017) Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Eur Respir Rev 26:160119.CrossRef Lang I, Meyer BC, Ogo T et al (2017) Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Eur Respir Rev 26:160119.CrossRef
Metadata
Title
Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: a pictorial essay for the interventional radiologist
Authors
Yolanda C. Bryce
Rocio Perez-Johnston
Errol B. Bryce
Behrang Homayoon
Ernesto G. Santos-Martin
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 1/2019
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-019-0695-9

Other articles of this Issue 1/2019

Insights into Imaging 1/2019 Go to the issue